Kimberly R. Ledesma

1.3k total citations
29 papers, 956 citations indexed

About

Kimberly R. Ledesma is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Kimberly R. Ledesma has authored 29 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Medicine, 23 papers in Pharmacology and 7 papers in Epidemiology. Recurrent topics in Kimberly R. Ledesma's work include Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pneumonia and Respiratory Infections (5 papers). Kimberly R. Ledesma is often cited by papers focused on Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pneumonia and Respiratory Infections (5 papers). Kimberly R. Ledesma collaborates with scholars based in United States, China and Singapore. Kimberly R. Ledesma's co-authors include Vincent H. Tam, Elizabeth B. Hirsch, Jian Zhou, Michael Nikolaou, Kamilia Abdelraouf, Kai‐Tai Chang, Ming Hu, Jie He, Michael S. Schwartz and Mary Motyl and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Kimberly R. Ledesma

28 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly R. Ledesma United States 18 734 614 291 170 147 29 956
Michael A. Zhanel Canada 9 610 0.8× 389 0.6× 275 0.9× 183 1.1× 146 1.0× 10 877
Neang S. Ly United States 15 753 1.0× 538 0.9× 273 0.9× 129 0.8× 203 1.4× 24 1.0k
Courtney K. Lawrence Canada 7 573 0.8× 367 0.6× 204 0.7× 179 1.1× 152 1.0× 11 803
Marisa Winkler United States 14 858 1.2× 534 0.9× 263 0.9× 155 0.9× 159 1.1× 30 951
Debora Rubio-Aparicio United States 15 939 1.3× 600 1.0× 297 1.0× 238 1.4× 182 1.2× 20 1.1k
Sachin Bhagwat India 19 638 0.9× 530 0.9× 220 0.8× 190 1.1× 227 1.5× 47 1.0k
Justin R. Lenhard United States 16 527 0.7× 365 0.6× 174 0.6× 130 0.8× 172 1.2× 29 735
Catharine C. Bulik United States 18 736 1.0× 739 1.2× 415 1.4× 255 1.5× 79 0.5× 26 1.0k
Amy N. Schilling United States 14 489 0.7× 514 0.8× 261 0.9× 189 1.1× 141 1.0× 19 913
Jovan Jacob Australia 9 1.1k 1.5× 923 1.5× 558 1.9× 178 1.0× 90 0.6× 9 1.3k

Countries citing papers authored by Kimberly R. Ledesma

Since Specialization
Citations

This map shows the geographic impact of Kimberly R. Ledesma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly R. Ledesma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly R. Ledesma more than expected).

Fields of papers citing papers by Kimberly R. Ledesma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly R. Ledesma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly R. Ledesma. The network helps show where Kimberly R. Ledesma may publish in the future.

Co-authorship network of co-authors of Kimberly R. Ledesma

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly R. Ledesma. A scholar is included among the top collaborators of Kimberly R. Ledesma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly R. Ledesma. Kimberly R. Ledesma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledesma, Kimberly R., et al.. (2021). Simultaneous in vitro simulation of multiple antimicrobial agents with different elimination half-lives in a pre-clinical infection model. Computers & Chemical Engineering. 155. 107540–107540. 6 indexed citations
2.
Zhou, Jian, et al.. (2019). The impact of serum protein binding on bacterial killing of minocycline. Journal of Global Antimicrobial Resistance. 21. 252–254.
3.
Tam, Vincent H., et al.. (2019). Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model. Antimicrobial Agents and Chemotherapy. 64(3). 3 indexed citations
4.
Tam, Vincent H., Cynthia Pérez, Kimberly R. Ledesma, & Russell E. Lewis. (2018). Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic‐susceptible and multidrug‐resistant Pseudomonas aeruginosa. Microbiology and Immunology. 62(4). 291–294. 7 indexed citations
5.
Manchandani, Pooja, et al.. (2017). Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity. Antimicrobial Agents and Chemotherapy. 61(4). 35 indexed citations
6.
Tam, Vincent H., Kai‐Tai Chang, Jian Zhou, et al.. (2017). Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 72(5). 1421–1428. 76 indexed citations
7.
Manchandani, Pooja, Jian Zhou, Kimberly R. Ledesma, et al.. (2015). Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model. Antimicrobial Agents and Chemotherapy. 60(2). 1029–1034. 49 indexed citations
8.
He, Jie, Kamilia Abdelraouf, Kimberly R. Ledesma, Diana S‐L Chow, & Vincent H. Tam. (2013). Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model. International Journal of Antimicrobial Agents. 42(6). 559–564. 39 indexed citations
9.
Hirsch, Elizabeth B., Kai‐Tai Chang, Paola Zucchi, et al.. (2013). An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. Journal of Infection and Chemotherapy. 20(3). 224–227. 10 indexed citations
10.
Hirsch, Elizabeth B., et al.. (2012). Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae. The Journal of Infectious Diseases. 207(5). 786–793. 46 indexed citations
11.
Hirsch, Elizabeth B., et al.. (2012). In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy. 56(7). 3753–3757. 124 indexed citations
12.
Singh, Renu, Michelle C. Swick, Kimberly R. Ledesma, et al.. (2012). Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 56(4). 1680–1685. 62 indexed citations
13.
Hirsch, Elizabeth B., et al.. (2012). Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors. Antimicrobial Agents and Chemotherapy. 56(5). 2237–2240. 54 indexed citations
14.
Guo, Beining, Kamilia Abdelraouf, Kimberly R. Ledesma, et al.. (2011). Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 55(10). 4601–4605. 26 indexed citations
15.
Yuan, Zhe, Kimberly R. Ledesma, Renu Singh, et al.. (2010). Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug‐Resistant Bacteria in a Murine Pneumonia Model. The Journal of Infectious Diseases. 201(6). 889–897. 24 indexed citations
16.
Singh, Renu, Kimberly R. Ledesma, Kai‐Tai Chang, & Vincent H. Tam. (2010). Impact of recA on Levofloxacin Exposure-Related Resistance Development. Antimicrobial Agents and Chemotherapy. 54(10). 4262–4268. 21 indexed citations
17.
Tam, Vincent H., et al.. (2009). Killing of Escherichia coli by β-lactams at different inocula. Diagnostic Microbiology and Infectious Disease. 64(2). 166–171. 15 indexed citations
18.
Tam, Vincent H., Kimberly R. Ledesma, Amy N. Schilling, et al.. (2009). In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing. Diagnostic Microbiology and Infectious Disease. 64(4). 427–433. 16 indexed citations
19.
Tam, Vincent H., et al.. (2008). Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii : Identifying Dosing Regimens To Suppress Resistance Development. Antimicrobial Agents and Chemotherapy. 52(11). 3987–3993. 39 indexed citations
20.
Lim, Tze-Peng, Kimberly R. Ledesma, Kai‐Tai Chang, et al.. (2008). Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 52(8). 2898–2904. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Zhanel Breakdown of academic impact, for papers by Neang S. Ly Breakdown of academic impact, for papers by Courtney K. Lawrence Breakdown of academic impact, for papers by Marisa Winkler Breakdown of academic impact, for papers by Debora Rubio-Aparicio Breakdown of academic impact, for papers by Sachin Bhagwat Breakdown of academic impact, for papers by Justin R. Lenhard Breakdown of academic impact, for papers by Catharine C. Bulik Breakdown of academic impact, for papers by Amy N. Schilling Breakdown of academic impact, for papers by Jovan Jacob
Rankless by CCL
2026